🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/11/2007 | 16,84 | 16,84 | 15,42 | 16,13 | -4,22% | 8,44% | 134.144 |
| 19/11/2007 | 16,66 | 16,88 | 15,91 | 16,84 | -0,44% | 5,84% | 135.828 |
| 16/11/2007 | 18,08 | 18,08 | 16,84 | 16,92 | -6,22% | 6,83% | 162.998 |
| 15/11/2007 | 18,04 | 18,23 | 17,40 | 18,04 | -0,21% | 4,56% | 105.851 |
| 14/11/2007 | 18,12 | 18,12 | 17,07 | 18,08 | +0,42% | 5,78% | 144.724 |
| 13/11/2007 | 18,23 | 18,38 | 17,48 | 18,00 | -0,62% | 4,93% | 148.224 |
| 12/11/2007 | 18,23 | 18,45 | 17,89 | 18,12 | -0,41% | 3,08% | 162.705 |
| 09/11/2007 | 19,35 | 19,35 | 17,85 | 18,19 | -3,38% | 7,74% | 173.658 |
| 08/11/2007 | 19,24 | 19,54 | 18,23 | 18,83 | -0,59% | 6,81% | 130.244 |
| 07/11/2007 | 19,99 | 19,99 | 18,90 | 18,94 | -6,47% | 5,43% | 142.346 |
| 06/11/2007 | 19,09 | 20,32 | 19,05 | 20,25 | +5,66% | 6,67% | 99.065 |
| 05/11/2007 | 19,50 | 19,95 | 18,75 | 19,16 | -6,40% | 6,14% | 113.840 |
| 02/11/2007 | 18,98 | 20,66 | 18,71 | 20,47 | +9,40% | 10,26% | 310.768 |
| 01/11/2007 | 19,84 | 19,84 | 18,71 | 18,71 | -7,06% | 5,66% | 271.655 |
| 31/10/2007 | 19,28 | 20,32 | 19,13 | 20,14 | +3,06% | 6,21% | 140.049 |
| 30/10/2007 | 19,69 | 19,84 | 19,39 | 19,54 | -0,95% | 2,28% | 73.230 |
| 29/10/2007 | 19,73 | 19,73 | 19,50 | 19,73 | +0,19% | 1,14% | 44.777 |
| 26/10/2007 | 20,25 | 20,25 | 19,50 | 19,69 | -1,31% | 3,70% | 126.958 |
| 25/10/2007 | 20,32 | 20,40 | 19,69 | 19,95 | -0,74% | 3,50% | 102.111 |
| 24/10/2007 | 20,21 | 20,44 | 19,69 | 20,10 | -1,29% | 3,70% | 92.573 |
| 23/10/2007 | 20,17 | 20,36 | 19,61 | 20,36 | +2,45% | 3,71% | 78.681 |
| 22/10/2007 | 19,65 | 20,40 | 19,46 | 19,88 | +1,14% | 4,76% | 97.810 |
| 19/10/2007 | 21,00 | 21,00 | 19,54 | 19,65 | -6,42% | 6,95% | 160.300 |
| 18/10/2007 | 21,26 | 21,78 | 20,89 | 21,00 | -1,58% | 4,23% | 115.042 |
| 17/10/2007 | 21,71 | 22,08 | 20,25 | 21,34 | +0,35% | 8,45% | 216.859 |
| 16/10/2007 | 21,60 | 21,90 | 21,07 | 21,26 | -1,56% | 3,81% | 70.799 |
| 15/10/2007 | 22,27 | 23,21 | 21,52 | 21,60 | -3,19% | 7,56% | 133.770 |
| 12/10/2007 | 22,57 | 22,68 | 22,23 | 22,31 | -0,33% | 1,99% | 59.418 |
| 11/10/2007 | 22,01 | 23,24 | 21,82 | 22,38 | +2,57% | 6,46% | 162.197 |
| 10/10/2007 | 21,82 | 21,97 | 21,15 | 21,82 | +0,87% | 3,77% | 121.962 |